Papillary thyroid carcinoma and related thyroid neoplastic lesions: A light microscopic study with emphasis on nuclear changes

Tumori

Volumn 86, Issue 3, 2000, Pages 238-249

  Mai, Kien T ^a   Yazdi, Hossein M ^b   Perkins, D Garth ^b   Commons, A Susan ^b   Thomas, Jane ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE

Author keywords

Follicular adenoma; Nuclear changes; Papillary thyroid carcinoma

Indexed keywords

ARTICLE; CELL NUCLEUS; CHROMATIN; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSCOPY; THYROID CARCINOMA; THYROID TUMOR;

EID: 0033942183     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160008600312     Document Type: Article

References (63)

1. Ambros R.A., Trost R.C., Campbell A.Y., Lambert W.C.: Prognostic value of morphometry in papillary thyroid carcinoma. Hum. Pathol., 20: 215-218, 1989.
2. Apel R.L., Ezzat S., Bapat B.V., Pan N., LiVolsi V.A., Asa S.L.: Clonality of thyroid nodules in sporadic goiter. Diagn. Mol. Pathol., 4: 113-121, 1995.
3. Berho M., Suster S.: Clear nuclear changes in Hashimoto's thyroiditis. A clinicopathologic study of 12 cases. Ann. Clin. Lab. Sci., 25: 513-521, 1995.
4. Bond J.A., Wyllie F.S., Rowson J., Radulescu A., Wynford-Thomas D.: In vivo reconstruction of tumor initiation in a human epithelium. Oncogene, 10: 281-290, 1994.
5. Bounacer A., Wicker R., Caillou B., Cailleux A.F., Sarasin A., Schlumberger M., Suarez H.G.: High prevalence of activating ret proto-oncogene rearrangements in thyroid tumors from patients who had received external radiation. Oncogene, 15: 1263-1273, 1997.
6. Cetta F., Gori M., Raffaelli N., Baldi C., Montalto G.: Comment on clinical and prognostic relevance of Ret-PTC activation in patients with papillary thyroid carcinoma. J. Clin. Endocrinol. Metab., 84: 2257-2258, 1999.
7. Chan J.K.C., Saw D.: The grooved nucleus. A useful diagnostic criterion of papillary carcinoma of the thyroid. Am. J. Surg. Pathol., 10: 672-679, 1986.
8. Cheifetz R.E., Davis N.L., Robinson B.W., Berean K.W., LeRiche J.C.: Differentiation of thyroid neoplasms by evaluating epithelial membrane antigen, Leu-7 antigen, epidermal growth factor receptor, and DNA content. Am. J. Surg. Pathol., 167: 531-534, 1994.
9. Cho J.Y., Sagartz J.E., Capen C.C., Mazzaferri E.L., Jhiang S.M.: Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Oncogene, 18: 3659-3665, 1999.
10. Dominquez-Malagon H.R., Szymanski-Gomez J.J., Gaytan-Garcia S.R.: Optically clear and vacuolated nuclei. Two useful signs for the transoperative diagnosis of papillary carcinoma of the thyroid. Cancer, 62: 105-108, 1988.
11. Ezzat S., Zheng L., Freeman J.L., Rosen I.B., Asa S.L.: Oncogene profile of papillary thyroid carcinoma. Surgery, 125: 46-52, 1999.
12. Farid N.R., Zou M., Shi Y.: Genetics of follicular thyroid cancer. Endocrinol. Met. Clin. North Am., 24: 865-888, 1995.
13. Fink A., Tomlinson G., Freeman J.L., Rosen I.B., Asa S.L.: Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Modern Pathol., 9: 816-820, 1996.
14. Fischer A.H., Bond J.A., Taysavang P., Battles O.E., Wynford T.: Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am. J. Pathol., 153: 1443-1450, 1998.
15. Franssila K.O.: Is the differentiation between papillary and follicular thyroid carcinoma valid? Cancer, 32: 854-863, 1973.
16. Harach H.R., Franssila K.O., Wasenius V.W.: Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer, 56: 531-538, 1985.
17. Horie H., Yokogoshi Y., Tsuyuguchi M., Saito S.: Point mutation of ras and Gs subunit genes in thyroid tumors. Jap. J. Cancer Res., 86: 737-742, 1995.
18. Ishizaka Y., Kobayashi S., Ushijima T., Hirohashi S., Sugimura T., Nagao M.: Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by RT-PCR method. Oncogene, 6: 1667-1673, 1991.
19. Jhiang S.M., Cho J.Y., Furminger T.L., Sagartz J.E., Tong Q., Capen C.C., Mazzaferri E.L.: Thyroid carcinomas in RET/PTC transgenic mice. Recent Results Cancer Res., 154: 265-270, 1998.
20. Jhiang S.M., Cho J.Y., Furminger T.L., Sagartz J.E., Tong Q., Capen C.C., Mazzaferri E.L.: Thyroid carcinomas in RET/PTC transgenic mice. Recent Results Cancer Res., 154: 265-270, 1998.
21. Jhiang S.M., Sagartz J.E., Tong Q., Parker-Thornburg J., Capen C.C., Cho J.Y., Xing S., Ledent C.: Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology, 137: 375-378, 1996.
22. Kanrko C., Shamoto M., Niimi H., Osada A., Shimizu M., Shinzato M.: Studies on intranuclear inclusions and nuclear grooves in papillary thyroid cancer by light, scanning electron and transmission electron microscopy. Acta Cytol., 40: 417-422, 1996.
23. Kashyap V., Kaushik N., Bhambhani S., Das A.K., Luthra U.K.: Supportive role of image analysis and DNA ploidy pattern in the diagnosis of thyroid tumors. Diagn. Cytopathol., 8: 228-230, 1992.
24. Klugbauer S., Demidchik E.P., Lengfelder E., Rabes H.M.: Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl. Oncogene. 16: 671-675, 1998.
25. Komminoth P.: The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications. [Review]. Virchows Arch., 431: 1-9, 1997.
26. Lee T.K., Myers R.T., Bond M.G., Marshall R.B., Kardon B.: The significance of nuclear diameter in the biologic behavior of thyroid carcinomas: a retrospective study of 127 cases. Hum. Pathol., 18: 1252-1255, 1987.
27. Lew W., Orell S., Henderson D.W.: Intranuclear vacuoles in nonpapillary carcinoma of the thyroid. A report of three cases. Acta Cytol., 28: 581-586, 1984.
28. LiVolsi V.A., Asa S.L.: The demise of follicular carcinoma of the thyroid gland. Thyroid, 4: 233-236, 1994.
29. LiVolsi V.A., Merino M.J.: Worrisome histologic alterations following fine needle aspiration of the thyroid (WHAFF). Pathol. Annu., 19, part 1: 99-119, 1984.
30. Mai K.T., Perkins D.G., Commons A.S., Yazdi H.M., Thomas J., Meban S.: Infiltrating papillary thyroid carcinoma. Arch. Pathol. Lab. Med., 122: 166-171, 1998.
31. Mai K.T., Yazdi H.M., Commons A.S., Perkins D.G., McDonald L.: Neoplastic non-papillary thyroid carcinoma lesions with a fine chromatin pattern: the value of nuclear changes in cytopathological diagnosis and the possible pathogenetic significance. Pathol. Int., 49: 601-607, 1999.
32. Manenti G., Pilotti S., RE F.C., Della Porta G., Pierotti M.A.: Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Eur. J. Cancer, 30: 987-993, 1994.
33. Mayr B., Potter E., Goretzki P., Ruschoff J., Dietmaier W., Hoang-Vu C., Dralle H., Brabant G.: Expression of wild-type ret. ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany. Langenbecks Arch. Surg., 384: 54-59, 1999.
34. Miettinen M., Karkkainen P.: Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours. Virch. Archiv., 429: 213-219, 1996.
35. Mizuno T., Iwamoto K.S., Kyoizumi S., Nagamura H., Shinohara T., Koyama K., Seyama T., Hamatani K.: Preferential induction of RET/PTC1 rearrangement by X-ray irradiation. Oncogene, 19: 438-443, 2000.
36. Nikiforov Y.E., Koshoffer A., Nikiforova M., Stringer J., Fagin J.A.: Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas. Oncogene. 18: 6330-6334, 1999.
37. Nikiforov Y.E., Nikiforova M.N., Gnepp D.R., Fagin J.A.: Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene, 13: 687-693, 1996.
38. Oyama T., Suzski T., Hara F., Iino Y., Ishida T., Sakamoto A., Nakajima T.: N-ras mutation of thyroid tumor with special reference to the follicular type. Pathol. Int., 45: 45-50, 1995.
39. Pierotti M.A., Bongarzone I., Borello M.G., Grecco A., Pilotti S., Sozzi G.: Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer, 16: 1-14, 1996.
40. Powell D.J. Jr, Russell J., Nibu K., Li G., Rhee E., Liao M., Goldstein M., Keane W.M., Santoro M., Fusco A., Rothstein J.L.: The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res., 58: 5523-5528, 1998.
41. Raphael S.J., McKeown-Eyssen G., Asa S.L.: High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors. Mod. Pathol., 7: 295-300, 1994.
42. Rigaud C.: Papillary carcinoma of the thyroid: development of the histological criteria for diagnosis. Study of 29 cases and review of the literature. Ann. Pathol., 8: 211-219, 1988.
43. Rosai J., Carcangiu M.L., Dehellis R.A.: Papillary carcinoma. In: Atlas of tumor pathology of the thyroid gland. AFIP, Washington DC, pp. 65-121, 1992.
44. Rosai J., Zampi G., Carcangiu M.L.: Papillary carcinoma of the thyroid. A discussion of its several morphologic expressions, with particular emphasis on the follicular variant. Am. J. Surg. Pathol., 7: 809-816, 1983.
45. Sack M.J., Astengo-Osuna C., Lin B.T., Battifora H., LiVolsi VA: HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod. Pathol., 10: 668-674, 1997.
46. Salmon I., Gasperin P., Pasteels J.E., Heimann R., Kiss R.: Relationship between histopathologic typing and morphonuclear assessments of 238 thyroid lesions. Digital cell image analysis performed on Feulgen-stained nuclei from formalin-fixed, paraffin-embedded materials. Am. J. Clin. Pathol., 97: 776-786, 1992.
47. Salmon I., Kiss R., Franc B., Gasperin P., Heimann R., Pasteels J.L., Verhest A.: Comparison of morphonuclear features in normal, benign and neoplastic thyroid tissue by digital cell image analysis. Anal. Quant. Cytol. Histol., 14: 47-54, 1992.
48. Santoro M., Grieco M., Melillo R.M., Fusco A., Vecchio G.: Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation. Eur. J. Endocrinol., 133: 513-522, 1995.
49. Santoro M., Thomas G.A., Vecchio G., Williams G.H., Fusco A., Chiappetta G., Pozcharskaya V., Bogdanova T.I., Demidchik E.P., Cherstvoy E.D., Voscoboinik L., Tronko N.D., Carss A., Bunnell H., Tonnachera M., Parma J., Dumont J.E., Keller G., Hofler H., Williams E.D.: Gene rearrangement and Chernobyl related thyroid cancers. Br. J. Cancer, 82: 315-322, 2000.
50. Schelfhout L.J.D.M., Van Muijen G.N.P., Fleuren G.J.: Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinoma and follicular follicular adenoma. Am. J. Clin. Pathol., 92: 654-658, 1989.
51. Shi Y.F., Zou M.J., Schmidt H., Juhasz F., Stensky V., Robb D., Farid N.R.: High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Res., 51: 2690-2693, 1991.
52. Smida J., Salassidis K., Hieber L., Zitzelsberger H., Kellerer A.M., Demidchik E.P., Negele T., Spelsberg F., Lengfelder E., Werner M., Bauchinger M.: Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int. J. Cancer, 80: 32-38, 1999.
53. Soares P., Fonseca E., Wynford-Thomas D., Sobrinho-Simoes M.: Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J. Pathol., 185: 71-78, 1998.
54. Sugg S.L., Ezzat S., Rosen I.B., Freeman J.L., Asa S.L.: Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J. Clin. Endocrinol. Metab., 83: 4116-22, 1998.
55. Thomas G.A., Bunnell H., Cook H.A., Williams E.D., Nerovnya A., Cherstvoy E.D., Tronko N.D., Bogdanova T.I., Chiappetta G., Viglietto G., Pentimalli F., Salvatore G., Fusco A., Santoro M., Vecchio G.: High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J. Clin. Endocrinol. Metab., 84: 4232-4238, 1999.
56. van Hoeven K.H., Kovatich A.J., Miettinen M.: Immunocytochemical evaluation of HBME-1, CA 19-9, and CD-15 (Leu-M1)in fine-needle aspirates of thyroid nodules. Diag. Cytopathol., 18: 93-97, 1998.
57. Vickery A.L. Jr: Thyroid papillary carcinoma. Am. J. Surg. Pathol., 7: 8, 1983.
58. Viglietto G., Chiappetta G., Martinez-Tello F.J., Fukunaga F.H., Tallini G., Rigopoulou D., Visconti R., Mastro A., Santoro M., Fusco A.: RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene, 11: 1207-1210, 1995.
59. Wilson N.W., Pambakian H., Richardson T.C., Stokoe M.R., Makin C.A., Heyderman E.: Epithelial markers in thyroid carcinoma: an immunoperoxidase study. Histopathology, 10: 815-829, 1986.
60. Wirtschafter A., Schmidt R., Rosen D., Kundu N., Santoro M., Fusco A., Multhaupt H., Atkins J.P., Rosen M.R., Keane W.M., Rothstein J.L.: Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope, 107: 95-100, 1997.
61. Yamamoto Y., Izumi K., Otsuka H.: An immunohistochemical study of epithelial membrane antigen, cytokeratin and vimentin in papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types. Cancer, 70: 2326-2333, 1992.
62. Yamamoto Y., Maeda T., Izumi K., Otsuka H.: Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer, 65: 1173-1179, 1990.
63. Zikin H.J.: Follicular adenoma of the thyroid with intranuclear vacuoles and clear nuclei. A case report. Acta Cytol., 28: 587-591, 1984.